174 related articles for article (PubMed ID: 34266728)
21. Dosimetric feasibility of stereotactic body radiation therapy as an alternative to brachytherapy for definitive treatment of medically inoperable early stage endometrial cancer.
Jones R; Chen Q; Best R; Libby B; Crandley EF; Showalter TN
Radiat Oncol; 2014 Jul; 9():164. PubMed ID: 25059785
[TBL] [Abstract][Full Text] [Related]
22. Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study.
Chan P; Yeo I; Perkins G; Fyles A; Milosevic M
Radiat Oncol; 2006 May; 1():13. PubMed ID: 16722546
[TBL] [Abstract][Full Text] [Related]
23. Technological advances in radiotherapy for the treatment of localised prostate cancer.
Mangar SA; Huddart RA; Parker CC; Dearnaley DP; Khoo VS; Horwich A
Eur J Cancer; 2005 Apr; 41(6):908-21. PubMed ID: 15808957
[TBL] [Abstract][Full Text] [Related]
24. Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: The impact of tumor regression.
van de Bunt L; van der Heide UA; Ketelaars M; de Kort GA; Jürgenliemk-Schulz IM
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):189-96. PubMed ID: 15978745
[TBL] [Abstract][Full Text] [Related]
25. Intensity modulated proton beam radiation for brachytherapy in patients with cervical carcinoma.
Clivio A; Kluge A; Cozzi L; Köhler C; Neumann O; Vanetti E; Wlodarczyk W; Marnitz S
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):897-903. PubMed ID: 24119834
[TBL] [Abstract][Full Text] [Related]
26. Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer.
Halpern JA; Sedrakyan A; Hsu WC; Mao J; Daskivich TJ; Nguyen PL; Golden EB; Kang J; Hu JC
Cancer; 2016 Aug; 122(16):2496-504. PubMed ID: 27224858
[TBL] [Abstract][Full Text] [Related]
27. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
[TBL] [Abstract][Full Text] [Related]
28. Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task force.
Kunkler IH; Audisio R; Belkacemi Y; Betz M; Gore E; Hoffe S; Kirova Y; Koper P; Lagrange JL; Markouizou A; Pfeffer R; Villa S;
Ann Oncol; 2014 Nov; 25(11):2134-2146. PubMed ID: 24625455
[TBL] [Abstract][Full Text] [Related]
29. What is the best way to radiate the prostate in 2016?
Moon DH; Efstathiou JA; Chen RC
Urol Oncol; 2017 Feb; 35(2):59-68. PubMed ID: 27395453
[TBL] [Abstract][Full Text] [Related]
30. Impact of different treatment plans on EQD
Gul OV; Inan G; Basaran H
J Egypt Natl Canc Inst; 2021 Oct; 33(1):28. PubMed ID: 34604928
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Delivery Costs for External Beam Radiation Therapy and Brachytherapy for Locally Advanced Cervical Cancer Using Time-Driven Activity-Based Costing.
Bauer-Nilsen K; Hill C; Trifiletti DM; Libby B; Lash DH; Lain M; Christodoulou D; Hodge C; Showalter TN
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):88-94. PubMed ID: 29079120
[TBL] [Abstract][Full Text] [Related]
32. Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer.
Lanni TB; Grills IS; Kestin LL; Robertson JM
Am J Clin Oncol; 2011 Oct; 34(5):494-8. PubMed ID: 20805737
[TBL] [Abstract][Full Text] [Related]
33. [Can stereotactic body radiotherapy replace brachytherapy for locally advanced cervical cancer? French society for radiation oncology statement].
Chargari C; Renard S; Espenel S; Escande A; Buchheit I; Ducassou A; Peiffert D; Hannoun-Lévi JM
Cancer Radiother; 2020 Oct; 24(6-7):706-713. PubMed ID: 32753238
[TBL] [Abstract][Full Text] [Related]
34. Evolution of definitive external beam radiation therapy in the treatment of prostate cancer.
Daly T
World J Urol; 2020 Mar; 38(3):565-591. PubMed ID: 30850855
[TBL] [Abstract][Full Text] [Related]
35. Rates of rectal toxicity in patients treated with high dose rate brachytherapy as monotherapy compared to dose-escalated external beam radiation therapy for localized prostate cancer.
Parzen JS; Ye H; Gustafson G; Yan D; Martinez A; Chen PY; Ghilezan M; Sebastian E; Limbacher A; Krauss DJ
Radiother Oncol; 2020 Jun; 147():123-129. PubMed ID: 32276193
[TBL] [Abstract][Full Text] [Related]
36. Comparison of dosimetric parameters and acute toxicity of intensity-modulated and three-dimensional radiotherapy in patients with cervix carcinoma: A randomized prospective study.
Naik A; Gurjar OP; Gupta KL; Singh K; Nag P; Bhandari V
Cancer Radiother; 2016 Jul; 20(5):370-6. PubMed ID: 27368915
[TBL] [Abstract][Full Text] [Related]
37. Three-dimensional dose accumulation in pseudo-split-field IMRT and brachytherapy for locally advanced cervical cancer.
Sun B; Yang D; Esthappan J; Garcia-Ramirez J; Price S; Mutic S; Schwarz JK; Grigsby PW; Tanderup K
Brachytherapy; 2015; 14(4):481-9. PubMed ID: 25958039
[TBL] [Abstract][Full Text] [Related]
38. Triple-tandem high-dose-rate brachytherapy for early-stage medically inoperable endometrial cancer: Initial report on acute toxicity and dosimetric comparison to stereotactic body radiation therapy.
Kauffmann G; Wu T; Al-Hallaq H; Hasan Y
Brachytherapy; 2017; 16(1):141-146. PubMed ID: 27866953
[TBL] [Abstract][Full Text] [Related]
39. Impact of Brachytherapy Boost and Dose-escalated External Beam Radiotherapy in Margin Positive Cervical Cancer Treated With Chemotherapy and Radiation.
Ager BJ; Torgeson A; Francis SR; Burt LM; Gaffney DK; Cannon DM
Am J Clin Oncol; 2020 Jan; 43(1):35-42. PubMed ID: 31764024
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer.
Pötter R; Georg P; Dimopoulos JC; Grimm M; Berger D; Nesvacil N; Georg D; Schmid MP; Reinthaller A; Sturdza A; Kirisits C
Radiother Oncol; 2011 Jul; 100(1):116-23. PubMed ID: 21821305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
